16. Diabetes Care in the Hospital: Standards of Care in Diabetes-2023

Nuha A ElSayed, Grazia Aleppo, Vanita R Aroda, Raveendhara R Bannuru, Florence M Brown, Dennis Bruemmer, Billy S Collins, Marisa E Hilliard, Diana Isaacs, Eric L Johnson, Scott Kahan, Kamlesh Khunti, Jose Leon, Sarah K Lyons, Mary Lou Perry, Priya Prahalad, Richard E Pratley, Jane Jeffrie Seley, Robert C Stanton, Robert A Gabbay, on behalf of the American Diabetes Association, Nuha A ElSayed, Grazia Aleppo, Vanita R Aroda, Raveendhara R Bannuru, Florence M Brown, Dennis Bruemmer, Billy S Collins, Marisa E Hilliard, Diana Isaacs, Eric L Johnson, Scott Kahan, Kamlesh Khunti, Jose Leon, Sarah K Lyons, Mary Lou Perry, Priya Prahalad, Richard E Pratley, Jane Jeffrie Seley, Robert C Stanton, Robert A Gabbay, on behalf of the American Diabetes Association

Abstract

The American Diabetes Association (ADA) "Standards of Care in Diabetes" includes the ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations and a full list of Professional Practice Committee members, please refer to Introduction and Methodology. Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.

© 2022 by the American Diabetes Association.

References

    1. Seisa MO, Saadi S, Nayfeh T, et al. . A systematic review supporting the Endocrine Society clinical practice guideline for the management of hyperglycemia in adults hospitalized for noncritical illness or undergoing elective surgical procedures. J Clin Endocrinol Metab 2022;107:2139–2147
    1. Korytkowski MT, Muniyappa R, Antinori-Lent K, et al. . Management of hyperglycemia in hospitalized adult patients in non-critical care settings: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2022;107:2101–2128
    1. Rubin DJ, Shah AA. Predicting and preventing acute care re-utilization by patients with diabetes. Curr Diab Rep 2021;21:34.
    1. Moghissi E, Inzucchi S. The evolution of glycemic control in the hospital setting. In Managing Diabetes and Hyperglycemia in the Hospital Setting. Draznin B, Ed. Alexandria, VA, American Diabetes Association, 2016, pp. 1–10
    1. Pasquel FJ, Gomez-Huelgas R, Anzola I, et al. . Predictive value of admission hemoglobin a1c on inpatient glycemic control and response to insulin therapy in medicine and surgery patients with type 2 diabetes. Diabetes Care 2015;38:e202–e203
    1. Umpierrez GE, Reyes D, Smiley D, et al. . Hospital discharge algorithm based on admission HbA1c for the management of patients with type 2 diabetes. Diabetes Care 2014;37:2934–2939
    1. Carpenter DL, Gregg SR, Xu K, Buchman TG, Coopersmith CM. Prevalence and impact of unknown diabetes in the ICU. Crit Care Med 2015;43:e541–e550
    1. Nanayakkara N, Nguyen H, Churilov L, et al. . Inpatient HbA1c testing: a prospective observational study. BMJ Open Diabetes Res Care 2015;3:e000113
    1. Nassar CM, Montero A, Magee MF. Inpatient diabetes education in the real world: an overview of guidelines and delivery models. Curr Diab Rep 2019;19:103.
    1. Donihi AC. Practical recommendations for transitioning patients with type 2 diabetes from hospital to home. Curr Diab Rep 2017;17:52.
    1. Garg R, Schuman B, Bader A, et al. . Effect of preoperative diabetes management on glycemic control and clinical outcomes after elective surgery. Ann Surg 2018;267:858–862
    1. van den Boom W, Schroeder RA, Manning MW, Setji TL, Fiestan GO, Dunson DB. Effect of A1C and glucose on postoperative mortality in noncardiac and cardiac surgeries. Diabetes Care 2018;41:782–788
    1. Setji T, Hopkins TJ, Jimenez M, et al. . Rationalization, development, and implementation of a preoperative diabetes optimization program designed to improve perioperative outcomes and reduce cost. Diabetes Spectr 2017;30:217–223
    1. Okabayashi T, Shima Y, Sumiyoshi T, et al. . Intensive versus intermediate glucose control in surgical intensive care unit patients. Diabetes Care 2014;37:1516–1524
    1. Institute of Medicine . Preventing Medication Errors. Aspden P, Wolcott J, Bootman JL, Cronenwett LR, Eds. Washington, DC, National Academies Press, 2007
    1. Gillaizeau F, Chan E, Trinquart L, et al. . Computerized advice on drug dosage to improve prescribing practice. Cochrane Database Syst Rev 2013;11:CD002894
    1. Sly B, Russell AW, Sullivan C. Digital interventions to improve safety and quality of inpatient diabetes management: a systematic review. Int J Med Inform 2022;157:104596.
    1. Wexler DJ, Shrader P, Burns SM, Cagliero E. Effectiveness of a computerized insulin order template in general medical inpatients with type 2 diabetes: a cluster randomized trial. Diabetes Care 2010;33:2181–2183
    1. Schnipper JL, Liang CL, Ndumele CD, Pendergrass ML. Effects of a computerized order set on the inpatient management of hyperglycemia: a cluster-randomized controlled trial. Endocr Pract 2010;16:209–218
    1. Nguyen M, Jankovic I, Kalesinskas L, Baiocchi M, Chen JH. Machine learning for initial insulin estimation in hospitalized patients. J Am Med Inform Assoc 2021;28:2212–2219
    1. Akiboye F, Sihre HK, Al Mulhem M, Rayman G, Nirantharakumar K, Adderley NJ. Impact of diabetes specialist nurses on inpatient care: a systematic review. Diabet Med 2021;38:e14573.
    1. Wang YJ, Seggelke S, Hawkins RM, et al. . Impact of glucose management team on outcomes of hospitalizaron in patients with type 2 diabetes admitted to the medical service. Endocr Pract 2016;22:1401–1405
    1. Draznin B, Gilden J, Golden SH, et al. .; PRIDE investigators . Pathways to quality inpatient management of hyperglycemia and diabetes: a call to action. Diabetes Care 2013;36:1807–1814
    1. Bansal V, Mottalib A, Pawar TK, et al. . Inpatient diabetes management by specialized diabetes team versus primary service team in non-critical care units: impact on 30-day readmission rate and hospital cost. BMJ Open Diabetes Res Care 2018;6:e000460
    1. Ostling S, Wyckoff J, Ciarkowski SL, et al. . The relationship between diabetes mellitus and 30-day readmission rates. Clin Diabetes Endocrinol 2017;3:3.
    1. Rushakoff RJ, Sullivan MM, MacMaster HW, et al. . Association between a virtual glucose management service and glycemic control in hospitalized adult patients: an observational study. Ann Intern Med 2017;166:621–627
    1. Endocrine Society . Clinical Practice Guidelines. Accessed 30 August 2022. Available from
    1. Magee MF, Baker KM, Bardsley JK, Wesley D, Smith KM. Diabetes to go-inpatient: pragmatic lessons learned from implementation of technology-enabled diabetes survival skills education within nursing unit workflow in an urban, tertiary care hospital. Jt Comm J Qual Patient Saf 2021;47:107–119
    1. Pinkhasova D, Swami JB, Patel N, et al. . Patient understanding of discharge instructions for home diabetes self-management and risk for hospital readmission and emergency department visits. Endocr Pract 2021;27:561–566
    1. Society of Hospital Medicine . Glycemic control for hospitalists. Accessed 30 August 2022. Available from
    1. Arnold P, Scheurer D, Dake AW, et al. . Hospital guidelines for diabetes management and the Joint Commission-American Diabetes Association Inpatient Diabetes Certification. Am J Med Sci 2016;351:333–341
    1. Association of British Diabetologists . Joint British Diabetes Societies (JBDS) for Inpatient Care Group. Accessed 7 October 2022. Available from
    1. Moghissi ES, Korytkowski MT, DiNardo M, et al. .; American Association of Clinical Endocrinologists; American Diabetes Association . American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care 2009;32:1119–1131
    1. Umpierrez GE, Hellman R, Korytkowski MT, et al. .; Endocrine Society . Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2012;97:16–38
    1. Agiostratidou G, Anhalt H, Ball D, et al. . Standardizing clinically meaningful outcome measures beyond HbA1c for type 1 diabetes: a consensus report of the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators, the American Diabetes Association, the Endocrine Society, JDRF International, The Leona M. and Harry B. Helmsley Charitable Trust, the Pediatric Endocrine Society, and the T1D Exchange. Diabetes Care 2017;40:1622–1630
    1. Van den Berghe G, Wouters P, Weekers F, et al. . Intensive insulin therapy in critically ill patients. N Engl J Med 2001;345:1359–1367
    1. Finfer S, Chittock DR, Su SY, et al. .; NICE-SUGAR Study Investigators . Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009;360:1283–1297
    1. Kansagara D, Fu R, Freeman M, Wolf F, Helfand M. Intensive insulin therapy in hospitalized patients: a systematic review. Ann Intern Med 2011;154:268–282
    1. Sathya B, Davis R, Taveira T, Whitlatch H, Wu WC. Intensity of peri-operative glycemic control and postoperative outcomes in patients with diabetes: a meta-analysis. Diabetes Res Clin Pract 2013;102:8–15
    1. Umpierrez G, Cardona S, Pasquel F, et al. . randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary artery bypass graft surgery: GLUCO-CABG trial. Diabetes Care 2015;38:1665–1672
    1. Furnary AP, Wu Y, Bookin SO. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project. Endocr Pract 2004;10(Suppl. 2):21–33
    1. Low Wang CC, Draznin B. Practical approach to management of inpatient hyperglycemia in select patient populations. Hosp Pract (1995) 2013;41:45–53
    1. Magaji V, Nayak S, Donihi AC, et al. . Comparison of insulin infusion protocols targeting 110–140 mg/dL in patients after cardiac surgery. Diabetes Technol Ther 2012;14:1013–1017
    1. Flory JH, Aleman JO, Furst J, Seley JJ. Basal insulin use in the non-critical care setting: is fasting hypoglycemia inevitable or preventable? J Diabetes Sci Technol 2014;8:427–428
    1. Cobaugh DJ, Maynard G, Cooper L, et al. . Enhancing insulin-use safety in hospitals: Practical recommendations from an ASHP Foundation expert consensus panel. Am J Health Syst Pharm 2013;70:1404–1413
    1. Rice MJ, Coursin DB. Glucose meters: here today, gone tomorrow? Crit Care Med 2016;44:e97–e100
    1. Rice MJ, Smith JL, Coursin DB. Glucose measurement in the ICU: regulatory intersects reality. Crit Care Med 2017;45:741–743
    1. Klonoff DC, Draznin B, Drincic A, et al. . PRIDE statement on the need for a moratorium on the CMS plan to cite hospitals for performing point-of-care capillary blood glucose monitoring on critically ill patients. J Clin Endocrinol Metab 2015;100:3607–3612
    1. DuBois JA, Slingerland RJ, Fokkert M, et al. . Bedside glucose monitoring–is it safe? A new, regulatory-compliant risk assessment evaluation protocol in critically ill patient care settings. Crit Care Med 2017;45:567–574
    1. Zhang R, Isakow W, Kollef MH, Scott MG. Performance of a modern glucose meter in ICU and general hospital inpatients: 3 years of real-world paired meter and central laboratory results. Crit Care Med 2017;45:1509–1514
    1. Wallia A, Prince G, Touma E, El Muayed M, Seley JJ. Caring for hospitalized patients with diabetes mellitus, hyperglycemia, and COVID-19: bridging the remaining knowledge gaps. Curr Diab Rep 2020;20:77.
    1. Aljehani FA, Funke K, Hermayer KL. Inpatient diabetes and hyperglycemia management protocol in the COVID-19 era. Am J Med Sci 2020;360:423–426
    1. Pasquel FJ, Umpierrez GE. Individualizing inpatient diabetes management during the coronavirus disease 2019 pandemic. J Diabetes Sci Technol 2020;14:705–707
    1. Ceriello A, Standl E, Catrinoiu D, et al. .; “Diabetes and Cardiovascular Disease (D&CVD)” Study Group of the European Association for the Study of Diabetes (EASD) . Issues for the management of people with diabetes and COVID-19 in ICU. Cardiovasc Diabetol 2020;19:114.
    1. Korytkowski M, Antinori-Lent K, Drincic A, et al. . A pragmatic approach to inpatient diabetes management during the COVID-19 pandemic. J Clin Endocrinol Metab 2020;105:dgaa342.
    1. Sadhu AR, Serrano IA, Xu J, et al. . Continuous glucose monitoring in critically ill patients with COVID-19: results of an emergent pilot study. J Diabetes Sci Technol 2020;14:1065–1073
    1. Galindo RJ, Aleppo G, Klonoff DC, et al. . Implementation of continuous glucose monitoring in the hospital: emergent considerations for remote glucose monitoring during the COVID-19 pandemic. J Diabetes Sci Technol 2020;14:822–832
    1. Agarwal S, Mathew J, Davis GM, et al. . continuous glucose monitoring in the intensive care unit during the COVID-19 pandemic. Diabetes Care 2021;44:847–849
    1. Faulds ER, Jones L, McNett M, et al. . Facilitators and barriers to nursing implementation of continuous glucose monitoring (CGM) in critically ill patients with COVID-19. Endocr Pract 2021;27:354–361
    1. Longo RR, Elias H, Khan M, Seley JJ. Use and accuracy of inpatient CGM during the COVID-19 pandemic: an observational study of general medicine and ICU patients. J Diabetes Sci Technol 2021;16:1136–1143
    1. Davis GM, Spanakis EK, Migdal AL, et al. . Accuracy of Dexcom G6 continuous glucose monitoring in non-critically ill hospitalized patients with diabetes. Diabetes Care 2021;44:1641–1646
    1. Baker M, Musselman ME, Rogers R, Hellman R. Practical implementation of remote continuous glucose monitoring in hospitalized patients with diabetes. Am J Health Syst Pharm 2022;79:452–458
    1. Wright JJ, Williams AJ, Friedman SB, et al. . Accuracy of continuous glucose monitors for inpatient diabetes management. J Diabetes Sci Technol. 7 February 2022 [Epub ahead of print]. DOI: 10.1177/19322968221076562
    1. Braithwaite SS, Clark LP, Idrees T, Qureshi F, Soetan OT. hypoglycemia prevention by algorithm design during intravenous insulin infusion. Curr Diab Rep 2018;18:26.
    1. Maynard G, Wesorick DH, O’Malley C; Society of Hospital Medicine Glycemic Control Task Force . Subcutaneous insulin order sets and protocols: effective design and implementation strategies. J Hosp Med 2008;3(Suppl.):29–41
    1. Brown KE, Hertig JB. Determining current insulin pen use practices and errors in the inpatient setting. Jt Comm J Qual Patient Saf 2016;42:568–575, AP1–AP7
    1. Horne J, Bond R, Sarangarm P. Comparison of inpatient glycemic control with insulin vials versus insulin pens in general medicine patients. Hosp Pharm 2015;50:514–521
    1. Veronesi G, Poerio CS, Braus A, et al. . Determinants of nurse satisfaction using insulin pen devices with safety needles: an exploratory factor analysis. Clin Diabetes Endocrinol 2015;1:15.
    1. Najmi U, Haque WZ, Ansari U, et al. . Inpatient insulin pen implementation, waste, and potential cost savings: a community hospital experience. J Diabetes Sci Technol 2021;15:741–747
    1. U.S. Food and Drug Administration . FDA Drug Safety Communication: FDA requires label warnings to prohibit sharing of multi-dose diabetes pen devices among patients. Accessed 23 October 2022. Available from
    1. Bueno E, Benitez A, Rufinelli JV, et al. . Basal-bolus regimen with insulin analogues versus human insulin in medical patients with type 2 diabetes: a randomized controlled trial in Latin America. Endocr Pract 2015;21:807–813
    1. Dhatariya K, Corsino L, Umpierrez GE. Management of diabetes and hyperglycemia in hospitalized patients. In: Feingold KR, Anawalt B, Boyce A, et al., Eds. Endotext. South Dartmouth, MA, , Inc. Accessed 30 August 2022. Available from
    1. Sadhu AR, Patham B, Vadhariya A, Chikermane SG, Johnson ML. Outcomes of “real-world” insulin strategies in the management of hospital hyperglycemia. J Endocr Soc 2021;5:bvab101.
    1. Umpierrez GE, Smiley D, Jacobs S, et al. . Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care 2011;34:256–261
    1. Colunga-Lozano LE, Gonzalez Torres FJ, Delgado-Figueroa N, et al. . Sliding scale insulin for non-critically ill hospitalised adults with diabetes mellitus. Cochrane Database Syst Rev 2018;11:CD011296.
    1. Migdal AL, Fortin-Leung C, Pasquel F, Wang H, Peng L, Umpierrez GE. Inpatient glycemic control with sliding scale insulin in noncritical patients with type 2 diabetes: who can slide? J Hosp Med 2021;16:462–468
    1. Giugliano D, Chiodini P, Maiorino MI, Bellastella G, Esposito K. Intensification of insulin therapy with basal-bolus or premixed insulin regimens in type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Endocrine 2016;51:417–428
    1. Bellido V, Suarez L, Rodriguez MG, et al. . Comparison of basal-bolus and premixed insulin regimens in hospitalized patients with type 2 diabetes. Diabetes Care 2015;38:2211–2216
    1. Baldwin D, Zander J, Munoz C, et al. . A randomized trial of two weight-based doses of insulin glargine and glulisine in hospitalized subjects with type 2 diabetes and renal insufficiency. Diabetes Care 2012;35:1970–1974
    1. Iyengar R, Franzese J, Gianchandani R. Inpatient glycemic management in the setting of renal insufficiency/failure/dialysis. Curr Diab Rep 2018;18:75.
    1. Shomali ME, Herr DL, Hill PC, Pehlivanova M, Sharretts JM, Magee MF. Conversion from intravenous insulin to subcutaneous insulin after cardiovascular surgery: transition to target study. Diabetes Technol Ther 2011;13:121–126
    1. Draznin B. Transitioning from intravenous to subcutaneous insulin. In Managing Diabetes and Hyperglycemia in the Hospital Setting. Alexandria, VA, American Diabetes Association, 2016, p. 115–128
    1. Hsia E, Seggelke S, Gibbs J, et al. . Subcutaneous administration of glargine to diabetic patients receiving insulin infusion prevents rebound hyperglycemia. J Clin Endocrinol Metab 2012;97:3132–3137
    1. Lim Y, Ohn JH, Jeong J, et al. . Effect of the concomitant use of subcutaneous basal insulin and intravenous insulin infusion in the treatment of severe hyperglycemic patients. Endocrinol Metab (Seoul) 2022;37:444–454
    1. Tripathy PR, Lansang MC. U-500 regular insulin use in hospitalized patients. Endocr Pract 2015;21:54–58
    1. Lansang MC, Umpierrez GE. Inpatient hyperglycemia management: a practical review for primary medical and surgical teams. Cleve Clin J Med 2016;83(Suppl. 1):S34–S43
    1. Umpierrez GE, Gianchandani R, Smiley D, et al. . Safety and efficacy of sitagliptin therapy for the inpatient management of general medicine and surgery patients with type 2 diabetes: a pilot, randomized, controlled study. Diabetes Care 2013;36:3430–3435
    1. Pasquel FJ, Fayfman M, Umpierrez GE. Debate on insulin vs non-insulin use in the hospital setting-is it time to revise the guidelines for the management of inpatient diabetes? Curr Diab Rep 2019;19:65.
    1. Pasquel FJ, Lansang MC, Dhatariya K, Umpierrez GE. Management of diabetes and hyperglycaemia in the hospital. Lancet Diabetes Endocrinol 2021;9:174–188
    1. Fushimi N, Shibuya T, Yoshida Y, Ito S, Hachiya H, Mori A. Dulaglutide-combined basal plus correction insulin therapy contributes to ideal glycemic control in non-critical hospitalized patients. J Diabetes Investig 2020;11:125–131
    1. Fayfman M, Galindo RJ, Rubin DJ, et al. . A randomized controlled trial on the safety and efficacy of exenatide therapy for the inpatient management of general medicine and surgery patients with type 2 diabetes. Diabetes Care 2019;42:450–456
    1. Pérez-Belmonte LM, Osuna-Sánchez J, Millán-Gómez M, et al. . Glycaemic efficacy and safety of linagliptin for the management of non-cardiac surgery patients with type 2 diabetes in a real-world setting: Lina-Surg study. Ann Med 2019;51:252–261
    1. Vellanki P, Rasouli N, Baldwin D, et al. . Glycaemic efficacy and safety of linagliptin compared to basal-bolus insulin regimen in patients with type 2 diabetes undergoing non-cardiac surgery: a multicenter randomized clinical trial. Diabetes Obes Metab 2019;21:837–843
    1. U.S. Food and Drug Administration . FDA Drug Safety Communication: FDA adds warnings about heart failure risk to labels of type 2 diabetes medicines containing saxagliptin and alogliptin. Accessed 23 October 2022. Available from
    1. Levine JA, Karam SL, Aleppo G. SGLT2-I in the hospital setting: diabetic ketoacidosis and other benefits and concerns. Curr Diab Rep 2017;17:54.
    1. U.S. Food and Drug Administration . FDA revises labels of SGLT2 inhibitors for diabetes to include warnings about too much acid in the blood and serious urinary tract infections. Accessed 30 August 2022. Available from
    1. Akirov A, Grossman A, Shochat T, Shimon I. Mortality among hospitalized patients with hypoglycemia: insulin related and noninsulin related. J Clin Endocrinol Metab 2017;102:416–424
    1. Ilcewicz HN, Hennessey EK, Smith CB. Evaluation of the impact of an inpatient hyperglycemia protocol on glycemic control. J Pharm Pharm Sci 2019;22:85–92
    1. Sinha Gregory N, Seley JJ, Gerber LM, Tang C, Brillon D. Decreased rates of hypoglycemia following implementation of a comprehensive computerized insulin order set and titration algorithm in the inpatient setting. Hosp Pract (1995) 2016;44:260–265
    1. Amori RE, Pittas AG, Siegel RD, et al. . Inpatient medical errors involving glucose-lowering medications and their impact on patients: review of 2,598 incidents from a voluntary electronic error-reporting database. Endocr Pract 2008;14:535–542
    1. Alwan D, Chipps E, Yen PY, Dungan K. Evaluation of the timing and coordination of prandial insulin administration in the hospital. Diabetes Res Clin Pract 2017;131:18–32
    1. Korytkowski M, Dinardo M, Donihi AC, Bigi L, Devita M. Evolution of a diabetes inpatient safety committee. Endocr Pract 2006;12(Suppl. 3):91–99
    1. Hung AM, Siew ED, Wilson OD, et al. . Risk of hypoglycemia following hospital discharge in patients with diabetes and acute kidney injury. Diabetes Care 2018;41:503–512
    1. Maynard G, Kulasa K, Ramos P, et al. . Impact of a hypoglycemia reduction bundle and a systems approach to inpatient glycemic management. Endocr Pract 2015;21:355–367
    1. Milligan PE, Bocox MC, Pratt E, Hoehner CM, Krettek JE, Dunagan WC. Multifaceted approach to reducing occurrence of severe hypoglycemia in a large healthcare system. Am J Health Syst Pharm 2015;72:1631–1641
    1. Umpierrez G, Korytkowski M. Diabetic emergencies - ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia. Nat Rev Endocrinol 2016;12:222–232
    1. Galindo RJ, Umpierrez GE, Rushakoff RJ, et al. . Continuous glucose monitors and automated insulin dosing systems in the hospital consensus guideline. J Diabetes Sci Technol 2020;14:1035–1064
    1. Dagogo-Jack S. Hypoglycemia in type 1 diabetes mellitus: pathophysiology and prevention. Treat Endocrinol 2004;3:91–103
    1. Rickels MR. Hypoglycemia-associated autonomic failure, counterregulatory responses, and therapeutic options in type 1 diabetes. Ann N Y Acad Sci 2019;1454:68–79
    1. Dendy JA, Chockalingam V, Tirumalasetty NN, et al. . Identifying risk factors for severe hypoglycemia in hospitalized patients with diabetes. Endocr Pract 2014;20:1051–1056
    1. Ulmer BJ, Kara A, Mariash CN. Temporal occurrences and recurrence patterns of hypoglycemia during hospitalization. Endocr Pract 2015;21:501–507
    1. Shah BR, Walji S, Kiss A, James JE, Lowe JM. Derivation and validation of a risk-prediction tool for hypoglycemia in hospitalized adults with diabetes: the Hypoglycemia During Hospitalization (HyDHo) score. Can J Diabetes 2019;43:278–282.e1
    1. Mathioudakis NN, Everett E, Routh S, et al. . Development and validation of a prediction model for insulin-associated hypoglycemia in non-critically ill hospitalized adults. BMJ Open Diabetes Res Care 2018;6:e000499
    1. Curll M, Dinardo M, Noschese M, Korytkowski MT. Menu selection, glycaemic control and satisfaction with standard and patient-controlled consistent carbohydrate meal plans in hospitalised patients with diabetes. Qual Saf Health Care 2010;19:355–359
    1. Drincic AT, Knezevich JT, Akkireddy P. Nutrition and hyperglycemia management in the inpatient setting (meals on demand, parenteral, or enteral nutrition). Curr Diab Rep 2017;17:59.
    1. Draznin B. Food, fasting, insulin, and glycemic control in the hospital. In Managing Diabetes and Hyperglycemia in the Hospital Setting. Alexandria, VA, American Diabetes Association, 2016, p. 70–83
    1. Mabrey ME, Setji TL. Patient self-management of diabetes care in the inpatient setting: pro. J Diabetes Sci Technol 2015;9:1152–1154
    1. Shah AD, Rushakoff RJ. Patient self-management of diabetes care in the inpatient setting: con. J Diabetes Sci Technol 2015;9:1155–1157
    1. Yeh T, Yeung M, Mendelsohn Curanaj FA. Managing patients with insulin pumps and continuous glucose monitors in the hospital: to wear or not to wear. Curr Diab Rep 2021;21:7.
    1. Umpierrez GE, Klonoff DC. Diabetes technology update: use of insulin pumps and continuous glucose monitoring in the hospital. Diabetes Care 2018;41:1579–1589
    1. Houlden RL, Moore S. In-hospital management of adults using insulin pump therapy. Can J Diabetes 2014;38:126–133
    1. Korytkowski MT, Salata RJ, Koerbel GL, et al. . Insulin therapy and glycemic control in hospitalized patients with diabetes during enteral nutrition therapy: a randomized controlled clinical trial. Diabetes Care 2009;32:594–596
    1. Hsia E, Seggelke SA, Gibbs J, Rasouli N, Draznin B. Comparison of 70/30 biphasic insulin with glargine/lispro regimen in non-critically ill diabetic patients on continuous enteral nutrition therapy. Nutr Clin Pract 2011;26:714–717
    1. Olveira G, Abuín J, López R, et al. . Regular insulin added to total parenteral nutrition vs subcutaneous glargine in non-critically ill diabetic inpatients, a multicenter randomized clinical trial: INSUPAR trial. Clin Nutr 2020;39:388–394
    1. Draznin B. Glycemic control in the setting of parenteral or enteral nutrition via tube feeding. In Managing Diabetes and Hyperglycemia in the Hospital Setting. Alexandria, VA, American Diabetes Association, 2016, p. 84–98
    1. Pichardo-Lowden AR, Fan CY, Gabbay RA. Management of hyperglycemia in the non-intensive care patient: featuring subcutaneous insulin protocols. Endocr Pract 2011;17:249–260
    1. Donihi AC, Raval D, Saul M, Korytkowski MT, DeVita MA. Prevalence and predictors of corticosteroid-related hyperglycemia in hospitalized patients. Endocr Pract 2006;12:358–362
    1. Roberts A, James J; Joint British Diabetes Societies (JBDS) for Inpatient Care . Management of hyperglycaemia and steroid (glucocorticoid) therapy: a guideline from the Joint British Diabetes Societies (JBDS) for Inpatient Care Group. Diabet Med 2018;35:1011–1017
    1. Kwon S, Hermayer KL, Hermayer K. Glucocorticoid-induced hyperglycemia. Am J Med Sci 2013;345:274–277
    1. Seggelke SA, Gibbs J, Draznin B. Pilot study of using neutral protamine Hagedorn insulin to counteract the effect of methylprednisolone in hospitalized patients with diabetes. J Hosp Med 2011;6:175–176
    1. Brady V, Thosani S, Zhou S, Bassett R, Busaidy NL, Lavis V. Safe and effective dosing of basal-bolus insulin in patients receiving high-dose steroids for hyper-cyclophosphamide, doxorubicin, vincristine, and dexamethasone chemotherapy. Diabetes Technol Ther 2014;16:874–879
    1. Cheng YC, Guerra Y, Morkos M, et al. . Insulin management in hospitalized patients with diabetes mellitus on high-dose glucocorticoids: management of steroid-exacerbated hyperglycemia. PLoS One 2021;16:e0256682.
    1. Bajaj MA, Zale AD, Morgenlander WR, Abusamaan MS, Mathioudakis N. Insulin dosing and glycemic outcomes among steroid-treated hospitalized patients. Endocr Pract 2022;28:774–779
    1. Todd LA, Vigersky RA. Evaluating perioperative glycemic control of non-cardiac surgical patients with diabetes. Mil Med 2021;186:e867–e872
    1. Aronson S, Murray S, Martin G, et al. .; Perioperative Enhancement Team (POET) . Roadmap for transforming preoperative assessment to preoperative optimization. Anesth Analg 2020;130:811–819
    1. Smiley DD, Umpierrez GE. Perioperative glucose control in the diabetic or nondiabetic patient. South Med J 2006;99:580–589; quiz 590–591
    1. Buchleitner AM, Martínez-Alonso M, Hernández M, Solà I, Mauricio D. Perioperative glycaemic control for diabetic patients undergoing surgery. Cochrane Database Syst Rev 2012;9:CD007315
    1. Draznin B. Preoperative, intraoperative, and postoperative glucose management. In Managing Diabetes and Hyperglycemia in the Hospital Setting. Alexandria, VA, American Diabetes Association, 2016, p. 129–144
    1. Duggan EW, Carlson K, Umpierrez GE. Perioperative hyperglycemia management: an update. Anesthesiology 2017;126:547–560
    1. Han HS, Kang SB. Relations between long-term glycemic control and postoperative wound and infectious complications after total knee arthroplasty in type 2 diabetics. Clin Orthop Surg 2013;5:118–123
    1. Demma LJ, Carlson KT, Duggan EW, Morrow JG 3rd, Umpierrez G. Effect of basal insulin dosage on blood glucose concentration in ambulatory surgery patients with type 2 diabetes. J Clin Anesth 2017;36:184–188
    1. Umpierrez GE, Smiley D, Hermayer K, et al. . Randomized study comparing a Basal-bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: basal plus trial. Diabetes Care 2013;36:2169–2174
    1. Harrison VS, Rustico S, Palladino AA, Ferrara C, Hawkes CP. Glargine co-administration with intravenous insulin in pediatric diabetic ketoacidosis is safe and facilitates transition to a subcutaneous regimen. Pediatr Diabetes 2017;18:742–748
    1. Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diabetes Care 2009;32:1335–1343
    1. Vellanki P, Umpierrez GE. Diabetic ketoacidosis: a common debut of diabetes among african americans with type 2 diabetes. Endocr Pract 2017;23:971–978
    1. Andrade-Castellanos CA, Colunga-Lozano LE, Delgado-Figueroa N, Gonzalez-Padilla DA. Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis. Cochrane Database Syst Rev 2016;1:CD011281
    1. Kitabchi AE, Umpierrez GE, Fisher JN, Murphy MB, Stentz FB. Thirty years of personal experience in hyperglycemic crises: diabetic ketoacidosis and hyperglycemic hyperosmolar state. J Clin Endocrinol Metab 2008;93:1541–1552
    1. Karajgikar ND, Manroa P, Acharya R, et al. . Addressing pitfalls in management of diabetic ketoacidosis with a standardized protocol. Endocr Pract 2019;25:407–412
    1. Dhatariya KK, Glaser NS, Codner E, Umpierrez GE. Diabetic ketoacidosis. Nat Rev Dis Primers 2020;6:40.
    1. Shepperd S, Lannin NA, Clemson LM, McCluskey A, Cameron ID, Barras SL. Discharge planning from hospital to home. Cochrane Database Syst Rev 1996;1:CD000313
    1. Gregory NS, Seley JJ, Dargar SK, Galla N, Gerber LM, Lee JI. Strategies to prevent readmission in high-risk patients with diabetes: the importance of an interdisciplinary approach. Curr Diab Rep 2018;18:54.
    1. Rinaldi A, Snider M, James A, et al. . The impact of a diabetes transitions of care clinic on hospital utilization and patient care. Ann Pharmacother. 9 June 2022 [Epub ahead of print]. DOI: 10.1177/10600280221102557
    1. Patel N, Swami J, Pinkhasova D, et al. . Sex differences in glycemic measures, complications, discharge disposition, and postdischarge emergency room visits and readmission among non-critically ill, hospitalized patients with diabetes. BMJ Open Diabetes Res Care 2022;10:e002722
    1. Agency for Healthcare Research and Quality . Patient Safety Network – Readmissions and adverse events after discharge, 2019. Accessed 23 October 2022. Available from
    1. Rubin DJ. Hospital readmission of patients with diabetes. Curr Diab Rep 2015;15:17.
    1. Jiang HJ, Stryer D, Friedman B, Andrews R. Multiple hospitalizations for patients with diabetes. Diabetes Care 2003;26:1421–1426
    1. Maldonado MR, D’Amico S, Rodriguez L, Iyer D, Balasubramanyam A. Improved outcomes in indigent patients with ketosis-prone diabetes: effect of a dedicated diabetes treatment unit. Endocr Pract 2003;9:26–32
    1. Wu EQ, Zhou S, Yu A, Lu M, Sharma H, Gill J, et al. . Outcomes associated with post-discharge insulin continuity in US patients with type 2 diabetes mellitus initiating insulin in the hospital. Hosp Pract (1995) 2012;40:40–48
    1. Hirschman KB, Bixby MB. Transitions in care from the hospital to home for patients with diabetes. Diabetes Spectr 2014;27:192–195
    1. Tuttle KR, Bakris GL, Bilous RW, et al. . Diabetic kidney disease: a report from an ADA Consensus Conference. Diabetes Care 2014;37:2864–2883
    1. Rubin DJ, Recco D, Turchin A, Zhao H, Golden SH. External Validation Of The Diabetes Early Re-Admission Risk Indicator (Derri). Endocr Pract 2018;24:527–541

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe